BlueWind RENOVA iStim™ System for the Treatment of OAB

NACompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

October 28, 2022

Study Completion Date

January 24, 2025

Conditions
Treatment of Patients Suffering From Overactive Bladder (OAB)
Interventions
DEVICE

RENOVA iStim™ System

Tibial implantable neuromodulation device

Trial Locations (23)

2650

University Hospital Antwerp, Antwerp

3000

UZ Leuven, Leuven

21076

Chesapeake Urology - Hanover, Hanover

21117

Chesapeake Urology - Owing Mills, Owings Mills

27707

Duke Urogynecology, Durham

29169

Southern Urogynocology, West Columbia

33615

Florida Urology Partners, Tampa

55125

Minnesota Urology, Woodbury

57105

Sanford Health, Sioux Falls

60010

Comprehensive Urologic Care, Lake Barrington

68114

Adult Pediatric Urology & Urogynecology, Omaha

71106

Regional Urology, LLC, Shreveport

92110

Kaiser Permanente, San Diego

92868

University of California Irvine, Orange

98195

University of Washington, Seattle

06850

Norwalk Urology, Norwalk

Unknown

Rijnstate Hospital, Arnhem

Academic Hospital Maastricht, Maastricht

Radboud University Medical Center, Nijmegen

UMC Utrecht, Utrecht

Birmingham Women's and Children's NHS Foundation Trust, Birmingham

8025 AB

Isala, Zwolle

W2 1NY

Imperial College, St. Mary's Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BlueWind Medical

INDUSTRY

NCT03596671 - BlueWind RENOVA iStim™ System for the Treatment of OAB | Biotech Hunter | Biotech Hunter